HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fiorenza Ferrari Selected Research

Electrolytes

10/2020Blood purification therapy with a hemodiafilter featuring enhanced adsorptive properties for cytokine removal in patients presenting COVID-19: a pilot study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fiorenza Ferrari Research Topics

Disease

12Acute Kidney Injury (Acute Renal Failure)
12/2023 - 11/2012
9Critical Illness (Critically Ill)
01/2022 - 11/2012
5COVID-19
04/2023 - 10/2020
3Septic Shock (Toxic Shock Syndrome)
02/2024 - 11/2012
3Heart Failure
05/2020 - 12/2019
2Sepsis (Septicemia)
02/2024 - 01/2017
2Chronic Renal Insufficiency
01/2022 - 01/2019
1Multiple Organ Failure (MODS)
02/2024
1Infections
02/2024
1postintensive care syndrome
11/2023
1Drug Overdose
01/2023
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2023
1Poisoning
01/2023
1Hemolysis
01/2023
1Kidney Diseases (Kidney Disease)
01/2022
1Leukocytosis (Pleocytosis)
01/2022
1Pneumonia (Pneumonitis)
01/2021
1IgG Deficiency
01/2021
1Respiratory Insufficiency (Respiratory Failure)
01/2021
1Hemorrhage
10/2020
1Inflammation (Inflammations)
10/2020
1Thromboembolism
10/2020
1Body Weight (Weight, Body)
01/2020
1Shock
01/2020
1Diabetes Mellitus
01/2020
1Ascites
12/2019
1Thrombosis (Thrombus)
05/2017
1Autosomal Dominant Polycystic Kidney (ADPKD)
02/2017

Drug/Important Bio-Agent (IBA)

4Biomarkers (Surrogate Marker)IBA
01/2019 - 02/2017
3AnticoagulantsIBA
01/2023 - 11/2012
3CreatinineIBA
01/2022 - 01/2018
2Anti-Bacterial Agents (Antibiotics)IBA
02/2024 - 05/2020
2Heparin (Liquaemin)FDA LinkGeneric
01/2022 - 10/2020
2CytokinesIBA
11/2020 - 10/2020
2Insulin-Like Growth Factor Binding ProteinsIBA
11/2019 - 01/2019
1Hemoglobins (Hemoglobin)IBA
01/2023
1HaptoglobinsIBA
01/2023
1ProcalcitoninIBA
01/2022
1MCOIBA
01/2022
1Immunoglobulin G (IgG)IBA
01/2021
1Immunoglobulins (Immunoglobulin)IBA
01/2021
1Antiviral Agents (Antivirals)IBA
01/2021
1Indicators and Reagents (Reagents)IBA
01/2021
1Oxygen (Dioxygen)IBA
01/2021
1ElectrolytesIBA
10/2020
1Interleukin-6 (Interleukin 6)IBA
10/2020
1Lipocalin-2IBA
05/2020
1CatecholaminesIBA
01/2020
1Cefoxitin (Cefoxitin Sodium)FDA LinkGeneric
01/2020
1insulin-like growth factor binding protein-related protein 1IBA
01/2018

Therapy/Procedure

7Therapeutics
02/2024 - 01/2017
6Renal Replacement Therapy (Therapies, Renal Replacement)
04/2023 - 11/2012
5Continuous Renal Replacement Therapy
01/2023 - 12/2019
3Extracorporeal Membrane Oxygenation
01/2023 - 01/2021
3Hemoperfusion
01/2023 - 01/2017
2Renal Dialysis (Hemodialysis)
01/2022 - 05/2017
2Length of Stay
01/2021 - 01/2019
2Catheters
10/2020 - 12/2019
1Critical Care (Surgical Intensive Care)
12/2023
1Nutritional Support (Artificial Feeding)
11/2023
1Continuous Positive Airway Pressure
01/2021
1Cardiopulmonary Bypass (Heart-Lung Bypass)
01/2020
1Minimally Invasive Surgical Procedures
01/2020
1Peritoneal Dialysis
12/2019